Tandem Diabetes Care Inc (TNDM)
Debt-to-equity ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | 285,035 | 283,232 | 281,467 | 202,984 | 0 |
| Total stockholders’ equity | US$ in thousands | 313,632 | 439,947 | 433,112 | 366,305 | 194,979 |
| Debt-to-equity ratio | 0.91 | 0.64 | 0.65 | 0.55 | 0.00 |
December 31, 2023 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $285,035K ÷ $313,632K
= 0.91
The debt-to-equity ratio of Tandem Diabetes Care Inc has shown an increasing trend over the past five years, indicating a higher reliance on debt relative to equity in financing its operations.
In 2019, the company had no debt, resulting in a debt-to-equity ratio of 0.00, suggesting a capital structure solely reliant on equity. However, in subsequent years, there was a significant shift as the ratio rose to 0.55 in 2020, and continued to increase to 0.65 in 2021 and 0.64 in 2022, reaching 0.91 in 2023.
This escalating trend in the debt-to-equity ratio may imply that Tandem Diabetes Care Inc has been taking on more debt to fund its growth or operations, potentially increasing its financial leverage and risk profile. Investors and stakeholders may want to closely monitor the company's ability to manage its debt levels and ensure sustainable growth in the long term.
Peer comparison
Dec 31, 2023